The Full Wiki

More info on TNFSF13

TNFSF13: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

edit
Tumor necrosis factor (ligand) superfamily, member 13
Identifiers
Symbols TNFSF13; APRIL; CD256; TALL2; TRDL-1; UNQ383/PRO715; ligand
External IDs OMIM604472 MGI1916833 HomoloGene56971 GeneCards: TNFSF13 Gene
Orthologs
Species Human Mouse
Entrez 8741 69583
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) NM_003808 NM_023517
RefSeq (protein) NP_003799 NP_076006
Location (UCSC) n/a n/a
PubMed search [1] [2]

Tumor necrosis factor ligand superfamily member 13 is a protein that in humans is encoded by the TNFSF13 gene.[1][2] TNFSF13 has also been designated CD256 (cluster of differentiation 256).

The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Three alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.[2]

Contents

Interactions

TNFSF13 has been shown to interact with TNFRSF13B[3] and B-cell activating factor.[4]

References

  1. ^ Hahne M, Kataoka T, Schroter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D, Tschopp J (Oct 1998). "APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth". J Exp Med 188 (6): 1185–90. PMID 9743536.  
  2. ^ a b "Entrez Gene: TNFSF13 tumor necrosis factor (ligand) superfamily, member 13". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8741.  
  3. ^ Wu, Y; Bressette D, Carrell J A, Kaufman T, Feng P, Taylor K, Gan Y, Cho Y H, Garcia A D, Gollatz E, Dimke D, LaFleur D, Migone T S, Nardelli B, Wei P, Ruben S M, Ullrich S J, Olsen H S, Kanakaraj P, Moore P A, Baker K P (Nov. 2000). "Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS". J. Biol. Chem. (UNITED STATES) 275 (45): 35478–85. doi:10.1074/jbc.M005224200. ISSN 0021-9258. PMID 10956646.  
  4. ^ Roschke, Viktor; Sosnovtseva Svetlana, Ward Christopher D, Hong June S, Smith Rodger, Albert Vivian, Stohl William, Baker Kevin P, Ullrich Stephen, Nardelli Bernardetta, Hilbert David M, Migone Thi-Sau (Oct. 2002). "BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases". J. Immunol. (United States) 169 (8): 4314–21. ISSN 0022-1767. PMID 12370363.  

Further reading

  • Bossen C, Schneider P (2007). "BAFF, APRIL and their receptors: structure, function and signaling.". Semin. Immunol. 18 (5): 263–75. doi:10.1016/j.smim.2006.04.006. PMID 16914324.  
  • Tangye SG, Bryant VL, Cuss AK, Good KL (2007). "BAFF, APRIL and human B cell disorders.". Semin. Immunol. 18 (5): 305–17. doi:10.1016/j.smim.2006.04.004. PMID 16916610.  
  • Treml LS, Crowley JE, Cancro MP (2007). "BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.". Semin. Immunol. 18 (5): 297–304. doi:10.1016/j.smim.2006.07.001. PMID 16919470.  
  • Mackay F, Leung H (2007). "The role of the BAFF/APRIL system on T cell function.". Semin. Immunol. 18 (5): 284–9. doi:10.1016/j.smim.2006.04.005. PMID 16931039.  
  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.  
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.  
  • Shu HB, Hu WH, Johnson H (1999). "TALL-1 is a novel member of the TNF family that is down-regulated by mitogens.". J. Leukoc. Biol. 65 (5): 680–3. PMID 10331498.  
  • Cousin P, Billotte J, Chaubert P, Shaw P (2000). "Physical map of 17p13 and the genes adjacent to p53.". Genomics 63 (1): 60–8. doi:10.1006/geno.1999.6062. PMID 10662545.  
  • Kelly K, Manos E, Jensen G, et al. (2000). "APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death.". Cancer Res. 60 (4): 1021–7. PMID 10706119.  
  • Wu Y, Bressette D, Carrell JA, et al. (2001). "Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.". J. Biol. Chem. 275 (45): 35478–85. doi:10.1074/jbc.M005224200. PMID 10956646.  
  • Yu G, Boone T, Delaney J, et al. (2001). "APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.". Nat. Immunol. 1 (3): 252–6. doi:10.1038/79802. PMID 10973284.  
  • Gallouzi IE, Brennan CM, Steitz JA (2001). "Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock.". RNA 7 (9): 1348–61. doi:10.1017/S1355838201016089. PMID 11565755.  
  • López-Fraga M, Fernández R, Albar JP, Hahne M (2002). "Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase.". EMBO Rep. 2 (10): 945–51. doi:10.1093/embo-reports/kve198. PMID 11571266.  
  • Stein JV, López-Fraga M, Elustondo FA, et al. (2002). "APRIL modulates B and T cell immunity.". J. Clin. Invest. 109 (12): 1587–98. PMID 12070306.  
  • Litinskiy MB, Nardelli B, Hilbert DM, et al. (2002). "DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.". Nat. Immunol. 3 (9): 822–9. doi:10.1038/ni829. PMID 12154359.  
  • Roschke V, Sosnovtseva S, Ward CD, et al. (2002). "BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.". J. Immunol. 169 (8): 4314–21. PMID 12370363.  
  • Pradet-Balade B, Medema JP, López-Fraga M, et al. (2002). "An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein.". EMBO J. 21 (21): 5711–20. doi:10.1093/emboj/cdf565. PMID 12411489.  
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.  
  • Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMID 12975309.  

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message